Callan Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $30.8K | Hold |
21,089
| – | – | ﹤0.01% | 363 |
|
|
2024
Q4 | $44.9K | Hold |
21,089
| – | – | ﹤0.01% | 338 |
|
|
2024
Q3 | $59K | Hold |
21,089
| – | – | ﹤0.01% | 345 |
|
|
2024
Q2 | $49.1K | Hold |
21,089
| – | – | ﹤0.01% | 311 |
|
|
2024
Q1 | $94.3K | Hold |
21,089
| – | – | 0.01% | 290 |
|
|
2023
Q4 | $67.7K | Buy |
21,089
+1,865
| +10% | +$5.99K | 0.01% | 229 |
|
|
2023
Q3 | $60.9K | Hold |
19,224
| – | – | 0.01% | 198 |
|
|
2023
Q2 | $95.5K | Hold |
19,224
| – | – | 0.01% | 178 |
|
|
2023
Q1 | $95K | Hold |
19,224
| – | – | 0.01% | 178 |
|
|
2022
Q4 | $121K | Buy |
+19,224
| New | +$121K | 0.01% | 179 |
|